What is the treatment for ileal ulcers?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Ileal Ulcers

Treatment for ileal ulcers should be tailored based on disease severity, with high-dose mesalazine for mild disease, corticosteroids for moderate to severe disease, and surgery for refractory cases. 1

Treatment Algorithm Based on Disease Severity

Mild Disease

  • High-dose mesalazine (4g daily) is recommended as initial therapy for patients with mild ileocolonic Crohn's disease 1
  • Pentasa (a mesalazine formulation) is particularly effective for ileal ulcers as it releases more 5-ASA into the small intestine compared to other formulations 2
  • Patient preferences should be considered when selecting therapy to improve adherence and outcomes 1

Moderate to Severe Disease

  • Oral corticosteroids such as prednisolone 40 mg daily are recommended for:
    • Patients with moderate to severe disease
    • Patients with mild to moderate disease who have failed to respond to mesalazine 1
  • Prednisolone should be tapered gradually over approximately 8 weeks to prevent early relapse 1
  • Systemic corticosteroids are potent and fast-acting but are not effective for maintaining remission 2

Alternative and Adjunctive Therapies

  • Elemental or polymeric diets can be used to induce remission in patients with:
    • Contraindications to corticosteroid therapy
    • Preference to avoid steroids 1
  • Metronidazole (10-20 mg/kg/day) can be effective but is not typically recommended as first-line therapy due to potential side effects 1
  • For corticosteroid-dependent or unresponsive cases, immunomodulators should be considered, including:
    • Azathioprine/6-mercaptopurine
    • Methotrexate
    • Cyclosporine 2
  • Biologics such as anti-TNF agents (infliximab, adalimumab) may be necessary for refractory cases 3

Surgical Management

  • Surgery should be considered for patients who have failed medical therapy 1
  • Primary surgical intervention may be appropriate for patients with limited ileal or ileo-caecal disease 1
  • Despite advances in medical therapy, a significant proportion of patients may eventually require surgical intervention 4

Common Pitfalls and Caveats

  • Avoid rapid reduction of corticosteroids as this is associated with early relapse 1
  • It is crucial to distinguish between Crohn's disease and ulcerative colitis, as treatment approaches differ significantly 1, 5
  • Always consider alternative explanations for symptoms beyond active disease, such as:
    • Bacterial overgrowth
    • Bile salt malabsorption
    • Fibrotic strictures 1
  • Prolonged corticosteroid treatment can lead to serious side effects; they should be gradually reduced once remission is achieved 2
  • For some patients with complex refractory disease, elective surgery may be a better alternative than prolonged conservative therapy after failure of first-line treatment 4

References

Guideline

Treatment of Ileal Ulcers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Drug therapy for ulcerative colitis.

World journal of gastroenterology, 2004

Research

Treatment of inflammatory bowel disease: a review of medical therapy.

World journal of gastroenterology, 2008

Guideline

Treatment for Collagenous Colitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.